antikoagulant

Antikoagulant is a substance that prevents or reduces the coagulation of blood. Coagulation, also known as blood clotting, is a vital process that stops bleeding when a blood vessel is injured. However, in certain medical conditions, excessive or inappropriate clotting can occur, leading to serious health problems like stroke, heart attack, or deep vein thrombosis. Antikoagulants work by interfering with the complex cascade of reactions that lead to clot formation.

There are several classes of antikoagulants. Warfarin, a vitamin K antagonist, is one of the oldest and most widely used. It inhibits the synthesis of vitamin K-dependent clotting factors. Newer oral antikoagulants, often referred to as NOACs or DOACs, target specific factors in the clotting cascade, such as Factor Xa or thrombin, offering more predictable effects and fewer drug interactions than warfarin. Parenteral antikoagulants, administered by injection, include heparins (unfractionated heparin and low molecular weight heparins) and direct thrombin inhibitors.

Antikoagulants are prescribed for a variety of medical reasons. They are essential in preventing blood clots in individuals with atrial fibrillation, mechanical heart valves, deep vein thrombosis, pulmonary embolism, and certain inherited clotting disorders. They are also used during and after surgery to reduce the risk of clot formation. The use of antikoagulants requires careful monitoring, as the risk of bleeding is a significant side effect. Dosage adjustments are often necessary based on individual patient factors and laboratory tests to maintain a balance between preventing unwanted clots and minimizing the risk of hemorrhage.